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During mitosis, genetic integrity of eukaryotic cells is critically dependent on the capture and stable attachment of microtubules (MTs) to the kinetochores. Kinetochores and MTs can be both regarded as nanodevices that interact and are able to create a machine capable of moving bulky objects such as chromosomes during cell division. Many of the MTs activities are mediated by interaction with a large number of microtubule associated proteins (MAPs), but knowledge is still fragmentary about how these proteins are involved and how the process is spatially and temporarily regulated within the cells. Poisons that affect MT function have been identified. Some, but not all, of these compounds, have clinical utility as anti-cancer drugs. Understanding the molecular mechanisms subtending to the function of microtubules and associated proteins is important to identify and characterize new molecular targets in anti-cancer therapy. The MT plus end is the contact surface between MTs and kinetochores, and to date, several associating proteins called +TIPs were identified as being specifically binding the microtubule plus end. We will investigate the interactions of +TIPs such as CLIP170 and EB1 with the Ndc80 complex, a constituent of the outer kinetochore that has recently emerged as a direct point of contact between kinetochores and microtubules.
The aim of the project will be to reconstitute in vitro, in part or entirely, a human MT-kinetochore complex interface and try to unveil the molecular mechanisms involved in the interactions between MTs and kinetochores.

Results
In last year’s report, we described our investigations of the interactions between CLIP170, Lis1 and Ndel1. The recombinant proteins fused to a GST-tag were produced by recombinant expression in bacteria and purified to homogeneity. Our N terminal “NT” construct of CLIP170 (residues 1-317), which contain a MT binding domain, has the ability to bind “in vitro” synthesized taxol-stabilized microtubules (Figure 1, lane 1-11).
The result relies on a well-known assay to study interaction of MAPs with microtubules by a co-sedimentation procedure. Taxol-stabilized MTs and proteins of interest are incubated and later subjected to a centrifugal force. The co-sedimentation of the protein with MTs denotes interaction. In our assay assays we observe MT binding for NT (lane 1-11). The addition of increasing amounts of a C-terminal “CT” contruct of CLIP170 (residues 1308-end) to the reaction leads to the displacement of CLIP170 from MTs. As reported previously, CLIP170 adopts a folded conformation mediated by the interaction of the NT and CT extremities (Figure 2A). Lis1 interacts with CT and the interaction unfolds CLIP170 (Figure 2B). Ndel1 interacts with Lis1 and competes for the binding to CLIP170 (Figure 2A). As shown in Figure 1, the binding of NT to MTs is dependent of the unfolding of CLIP170 by interaction of CT with one of its partners such as Lis1 (Figure 2C).

Figure 1 – microtubule co-sedimentation assay showing the partition of NT and CT in supernatant (S) and pellet fractions (P). Loading controls with CT (lane 1) and NT (lane 2) are marked as “Co”.

Figure 2 – model describing interactions network between NT and CT of CLIP170, with MTs, Lis1 and Ndel1. 

Using the co-sedimentation procedure, we identified an interaction of Ndc80 complex with MTs (Figure 3). The 4-protein 180-kDa Ndc80 complex, an evolutionary conserved and elongated constituent of the outer plate kinetochore is a direct contact point between kinetochores and MTs. A simplified version of the human Ndc80 complex, easier to produce and crystallize, was generated in the lab. In this shorter version, a large part of the coiled-coil region was removed, while the domains for MT binding and kinetochore localization were retained. The following results were obtained using this construct, which we have named Bonsai-Ndc80 complex. We measured the co-sedimentation of Bonsai Ndc80 as a function of increasing microtubules. In absence of MTs (Figure 3, lane 3-4), Bonsai was found in supernatant. With addition of MTs, increasing amounts of Bonsai complex were found in the pellet fractions (lanes 5-14). Several co-sedimentation assays (data not shown) suggest that Bonsai Ndc80 complex binds MTs with a KD of 0.6 µM. In a collaborative work with School of Crystallography, Birkbeck College, University of London, using negative stain electron microscopy (EM) of taxol and GMPCPP-stabilized microtubules, we were able to visualize Bonsai Ndc80 complex on MTs (Figure 4). 
 
	Figure 3 - microtubule co-sedimentation assay showing the partition of Bonsai Ndc8O complex in supernatant (S) and pellet fractions (P). Loading controls with tubulin (lane 1) and BSA with Bonsai complex (lane 2) are marked as “Co”.
	Figure 4 – negative stain electron microscopy images of taxol-stabilized MTs in absence (left) and presence (right) of bound bonsai Ndc80 complex. Insets are 2.5 x. Bar = 100 nm.

The MT binding domain of the Ndc80 complex is composed in one of its extremities of two proteins containing functional globular domains and called Hec1 and Nuf2 (Figure 6A). In an attempt to characterize the microtubule-binding interface of Ndc80 complex, single point mutations were introduced both in Hec1 or Nuf2 constructs. Using conservation and charge distribution data, the most conserved surface-exposed positively charged residues were chosen for mutagenesis. On Hec1 they are Lys89, Lys115, Lys123, Lys146, Lys156 and Lys166. On Nuf2 they are Lys29, Lys33, Lys41 and Lys115 (Figure 5A). We individually mutated them into alanine, which has a neutral charge, and tested their contribution towards MT binding. MTs are negatively charged structures, and the reduced charge of the alanine mutants of Lys89, Lys166 on Hec1 and of alanine mutants f Lys33 and Lys115 on Nuf2 strongly reduced co-sedimentation with MTs (Figure 5B). Moderate or insignificant effects were observed for the other mutants (data not shown). 

Figure 5 – (A) position of alanine mutants. Magenta: alanine mutants whose binding to MTs was severely affected. Pink: alanine mutants whose binding was moderately affected. Green: alanine mutant which did not affect MT binding. (B) MT co-sedimentation assay with Bonsai Ndc80 wild type complex (wt) and selected mutants. Loading controls with tubulin (lane 1) or Bonsai (lane2) are marked “Co”.

We also showed that Bonsai is released from MT in presence of different concentrations of active Aurora B kinase (Figure 6B). Aurora B adds negatively charged phosphate groups to the N-terminal region of Ndc80 complex. The N terminal region of Ndc80 has been shown to be important for high-affinity MT binding. A ΔN-Bonsai-Ndc80 complex, which lacks the N-terminal region (residues 1-80, Figure 7A), is strongly impaired in binding to MTs as compared to Bonsai (Figure 7B).
	Figure 6 – (A) schema of Bonsai Ndc80, Hec1  and Nuf2 heads (B) co-sedimentation assay, in which Aurora B (at the indicated concentrations) released Ndc80 from MTs. Loading controls with tubulin (lane1) or BSA plus Bonsai (lane 2) are marked with “Co”.

	Figure 7 – (A) schema of ΔN Bonsai Ndc80, Hec1  and Nuf2 heads (B) ability of Bonsai Ndc80 (FL) and ΔN Bonsai Ndc80 (ΔN) both at 1 µM to co-sediment with microtubules was tested at two microtubules concentrations.

In summary the results indicate that both Hec1 and Nuf2 are required for MT binding and make wide use of their positively charged residues and of the N-terminal region of Hec1 - which is also mainly positively charged - for high-affinity MT binding. These observations provide a good structural explanation for why the binding of the Ndc80 complex to MTs can be regulated by Aurora B. All these data strongly suggest that MTs and Ndc80 complex interactions are based on electrostatic interactions.

Future plans
We are currently investigating and characterizing the MT binding interface of the Ndc80 complex. Data from our laboratory suggest that there is cooperative binding of Ndc80 complex to MTs. It is unknown if the cooperative effect is achieved by “lateral” interactions and if N-terminal region of Hec1 is involved in these interactions. We will try to study the exact role of Hec1 N terminus tail by MT co-sedimentation or GST pull-down assays. Specifically, we will address 1) the specific mechanisms whereby the N-terminal tail contributes directly to the binding of MTs, and 2) the mechanisms that subtend to the interaction of additional Ndc80 molecules in a cooperative binding model. The answers coming from these results should tell us if the N-terminal region of Hec1 plays a key role in the cooperative binding to the MTs. Finally, we will design a small peptide that mimics N terminus of Hec1, and test it to see if it dismisses the binding of Ndc80 to the MTs. There is also work in collaboration with Peter de Wulf’s group to identify by high-throughput screening, a drug that inhibits the binding of Ndc80 to the MTs. For this reason, it is important to characterize in detail the binding interface between MTs and Ndc80. Other goals of the project will be to identify the binding partners of the Ndc80 complex by pull-down assays in mitotic extracts. In the future, we would like to describe in detail the role of these binding partners at the MT interface. 
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